SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001193125-23-252525
Filing Date
2023-10-10
Accepted
2023-10-06 21:40:31
Documents
7

Document Format Files

Seq Description Document Type Size
1 PRER14A d520772dprer14a.htm PRER14A 1088363
2 GRAPHIC g520772g00a02.jpg GRAPHIC 55749
3 GRAPHIC g520772g00a56.jpg GRAPHIC 692386
4 GRAPHIC g520772g01n59.jpg GRAPHIC 104005
5 GRAPHIC g520772g01p01.jpg GRAPHIC 226916
6 GRAPHIC g520772g02n59.jpg GRAPHIC 105564
7 GRAPHIC g520772g02p02.jpg GRAPHIC 214428
  Complete submission text file 0001193125-23-252525.txt   2996787
Mailing Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-37722 | Film No.: 231315301
SIC: 2834 Pharmaceutical Preparations